ABX Longevity Growth and Income Fund (ABXGX) | Abacus Asset Management
Abacus Asset Management

Closed-End Interval Fund  ·  Continuous Offering

ABX Longevity Growth & Income Fund

TickerABXGX StructureInterval Fund

The first registered interval fund* dedicated to the longevity asset class, investing 80% of its assets in longevity assets—built around a single, deeply personal metric: lifespan. ABXGX seeks long-term share appreciation and current income through an actively managed portfolio of U.S. longevity-based investments, delivering access to an institutional asset class once available only through private funds.

Contact Us View Fund Facts

* Based on life settlement / longevity-linked strategy data and prospectuses available. Source: Interval Fund Tracker (June 2026); Bloomberg FSRC (July 2026).

Fund Overview

A new way to invest in longevity

The ABX Longevity Growth and Income Fund is a non-diversified, closed-end interval fund registered under the Investment Company Act of 1940. Under normal circumstances, the Fund invests at least 80% of its total assets in U.S. longevity-based investments—primarily Mortality Contracts, and to a lesser extent, Annuity Contracts and structured finance products linked to longevity cash flows.

The Fund offers a continuous offering at daily net asset value, quarterly repurchase offers, and 1099-DIV tax reporting—pairing the discipline of a registered structure with an asset class whose cash flows are largely uncorrelated to equity and credit markets. Longevity Market Assets behave like mortality driven zero coupon bonds – performance driver being the mortality event, which is uncorrelated from most financial markets and economic variables.*

Sponsored by Longevity Market Assets, LLC. Managed by Abacus Asset Management.

Investment Highlights

Why ABXGX

01

Access to an Institutional Asset Class

Longevity investments, historically available only through private funds primarily driven by financial institutions, delivered in a registered fund structure.

02

Long-Term Appreciation & Current Income

Twin investment objectives pursued through an actively managed, diversified portfolio of Longevity Assets—at least 80% of total assets. Seeking ongoing accretion of longevity contracts and cash flows driven by mortality events.

03

Investment-Grade Counterparty Profile

Death benefit obligations are funded by U.S. life insurance carriers, which are state-regulated and typically high-investment-grade rated.

Investment grade refers to underlying insurance carrier and issuer of longevity contracts. Ratings are provided by AM Best. For the latest Best’s Credit Rating, access www.ambest.com.

04

Periodic Liquidity

A fundamental policy of quarterly repurchase offers (Mar, Jun, Sep, Dec) for at least 5% of outstanding Shares at NAV per Share.

The shares are illiquid and cannot be readily sold.

05

Backed by 20+ Years of Longevity Expertise

Leveraging enterprise expertise supported by transactions on over $10 billion in face value of life insurance assets.

—

Longevity, delivered with discipline

The same actuarial research and valuation methodology honed across the Abacus platform, now available in a registered fund.

The Opportunity

Why longevity assets?

The U.S. life insurance market represents one of the largest total addressable markets in alternative investments. A robust secondary market—where seniors sell unwanted policies for liquidity—and a growing investor-to-investor tertiary market are supported by durable demographic and capital-market tailwinds. Cash flows are largely uncorrelated to equity and credit markets and are ultimately funded by regulated U.S. life insurance carriers with performance driven by mortality events not linked to financial or economic factors.

$14T
Outstanding U.S. individual life insurance policies
$224B
Approximate annual secondary market
$31.4B
Tertiary, investor-to-investor market
63→75M
U.S. population age 65+, 2025 to 2034

Sources: ACLI 2024 Life Insurers Fact Book; A Conning Strategic Study (2025). Figures reflect long-term historical and projected market data; no assurance can be given that historical trends will continue.

Investment Strategy

How the portfolio is built

Under normal circumstances, the Fund invests at least 80% of its total assets in Longevity Assets. Core exposure consists of Mortality Contracts, supplemented by structured finance products linked to longevity cash flows and, where appropriate, Annuity Contracts to match premium obligations. Consistent with Section 17 of the Investment Company Act, the Fund sources policies from third-party providers rather than from Abacus Global Management or its affiliates.

Primary

Mortality Contracts

U.S. life insurance policies acquired primarily in the tertiary market, with targeted face value, age, impairment, and life-expectancy diversification.

Complementary

Structured Longevity

Notes and securities linked to portfolios of life insurance policies—excluding CDOs and derivatives—used for diversification and scaling.

Cash-Flow Matching

Annuity Contracts

Used selectively to fund ongoing premium obligations and reserve requirements.

Asset class characteristics

A comparison of common institutional asset classes across four characteristics investors weigh most.

U.S. Large
Cap Equity		 U.S. Fixed
Income		 Hedge
Funds		 Private
Equity		 Private
Credit		 Longevity
Assets
Low Volatility×✓××✓✓
Reliable Cash Flows*×✓××✓✓
Minimal Correlation to Markets×××××✓
Efficient Deployment✓✓××✓✓

* CashFlow is defined as payments made to the fund based on the death benefit value of the underlying life insurance policy issued by the Insurance carrier at the time of a mortality event.

Characteristics represent the adviser’s views and are not intended to depict the attributes of any actual investment product or provide a definitive comparison. Observations based on long-term historical asset class characteristics; no assurance historical trends will continue.

Actuarial Discipline

An enterprise track record of estimation

Accurate life-expectancy estimation is the foundation of longevity investing. Across the broader Abacus Global Management platform, policies have matured faster than expected—measured against the minimum life-expectancy / select-curve benchmark—at an actual-to-expected ratio of 110%. When we compare the outcome to what we expected, people are passing away earlier than projected, at about 110% of our expected rate (meaning roughly 10% more deaths than forecasted).

While the Fund will not invest in policies originated by Abacus, it benefits from the same underlying mortality research, valuation methodology, and proprietary data assets that produced this result.

Actual / Expected = 110%
Actual vs. Expected Cumulative Maturities  |  Abacus Originated Portfolio
0 500 1000 1500 2000 Cumulative Maturities Yr 1 Yr 2 Yr 3 Yr 4 Yr 5 Yr 6 Yr 7 Yr 8
Expected (E) Actual (A)

Reflects aggregate actual versus expected cumulative maturity experience on policies acquired by Abacus Global Management and its affiliates, measured against the minimum life expectancy / select-curve benchmark, on a cohort-tracked basis. For illustrative purposes only. Past risk profiles of Abacus’s originated longevity assets is not indicative of future risk profiles and is presented solely as evidence of enterprise mortality estimation expertise, not as a projection of Fund performance. Dataset represents all policies purchased by Abacus since 2018 (3,000 total insureds and 495 total maturities).

Fund Facts

Fund basics & liquidity

Fund Basics

Fund NameABX Longevity Growth and Income Fund
TickerABXGX
StructureClosed-end interval fund (1940 Act)
SponsorLongevity Market Assets, LLC
Investment ManagerAbacus Asset Management
Administrator / Transfer AgentUMB Fund Services, Inc.
Custodian (Assets)Wilmington Trust, N.A.
Custodian (Cash)M&T Bank Corp.
DistributorDistribution Services, LLC
Independent AuditorKPMG LLP
Tax ReportingForm 1099-DIV
Min. Initial / Subsequent$10,000 / $1,000

Liquidity & Distributions

Initial NAV$10.00 per Share
SubscriptionDaily, at NAV
Repurchase FrequencyQuarterly
Min. Repurchase Offer5% of Shares
Max. Repurchase Offer25% of Shares
Repurchase PricingNAV at Pricing Date
Distribution PolicyQuarterly; RIC pass-through

Shares are not listed on an exchange and are not readily redeemable; liquidity is provided through quarterly repurchase offers. There is no guarantee an investor will be able to tender all desired shares in any given quarter. Investors should consider shares of the Fund to be an illiquid investment.

Fees & Expenses2

Management Fee*Annual Rate of 1.45% of daily value of the Fund’s Managed Assets payable in arrears
Maximum Sales LoadUp to 5.00%
Redemption Fee1.00%4
Gross Expense Ratio53.00%
Net Expense Ratio5,61.75%

2 Fees reflect the Fund’s pre-effective registration statement and assume the Fund sells $50 million in shares during its first 12 months; actual expenses depend on Fund net assets. The Fund does not target a specific yield or total return.
4 Imposed on shares repurchased within 365 days that were acquired without an initial sales charge.
5 Gross expense ratio represents total annual expenses; Net expense ratio represents total annual expenses after fee waiver and expense reimbursement.
6 The Fund’s investment adviser has agreed to contractually reduce its fees and/or absorb expenses of the fund, at least until July 31, 2027, to ensure that the net annual fund operating expenses will not exceed 1.75% for its current share class, subject to possible recoupment from the Fund in future years. Without such waiver of fees and payment of expenses by the Adviser, expenses of the Fund would be higher and the Fund’s returns would be lower.
* Management Fee calculation detail is provided in the Important Disclosures below.

Interested in learning more?

Prospective investors will be provided with a prospectus, the amended prospectus, and other Fund documents. To request materials or speak with our team, get in touch.

Contact Us
Abacus Asset Management
Abacus Asset Management
333 S Garland Ave, Suite 1500, Orlando, FL 32801
Contact Us
Important Disclosures

Abacus Asset Management (“AAM”) is the investment adviser for ABX Longevity Growth and Income Fund (the “Fund”).

All securities investing and trading activities involve the risk of loss of capital. The Fund is subject to substantial risks, as outlined in the prospectus. The Fund is suitable only for a limited portion of an investment portfolio and is not a complete investment program. The Fund will invest in illiquid investments and itself has limited liquidity and is not suitable for all investors. There can be no assurance that the Fund’s investment objectives will be achieved, or that the Fund will achieve profits or avoid incurring substantial losses. An investor in the Fund could lose all or a substantial amount of their investment. Investors should closely review the Fund’s prospectus and statement of additional information for information about these and other risks associated with an investment in the Fund. For more information please view the Fund Prospectus and Amended Prospectus.

New Fund Risk. The Fund is a recently organized investment company with no operating history and track record on which prospective investors may base their investment decision.

Interval Fund Structure. The Fund is a non-diversified, closed-end interval fund registered under the Investment Company Act of 1940 (the “1940 Act”). Shares are not listed on an exchange and are not redeemable on a daily basis. Liquidity is provided through quarterly repurchase offers of at least 5% and not more than 25% of the Fund’s outstanding shares at net asset value. There is no guarantee an investor will be able to tender all shares the investor desires in any given quarter.

You may not have access to the money you invest for an extended period of time.

The Fund is not required to extend, and shareholders should not expect the Fund’s Board to authorize, repurchase offers in excess of 5% of the total outstanding shares per quarter. If shareholders tender for repurchase more than the Repurchase Offer Amount for a given repurchase offer, the Fund may, but is not required to, repurchase an additional amount of shares not to exceed 2% of the outstanding shares of the Fund.

Longevity Asset Risk. The Fund’s investments in mortality contracts (U.S. life insurance policies) and related longevity-linked instruments involve unique risks including longevity (life expectancy) risk, premium payment risk, credit risk of life insurance carriers, valuation risk, illiquidity, and regulatory risk. Actual mortality experience may differ materially from estimates.

Non-Diversified Fund. The Fund is non-diversified and may invest in a relatively small number of issuers, which may increase Fund volatility, and the impact of adverse developments affecting any single position may have a relatively outsize impact on Fund performance.

The amount of Distributions that the Fund may pay, if any, is uncertain.

The Fund may pay Distributions or repurchase shares from sources that may not be available in the future and that are unrelated to the Fund’s performance, such as from offering proceeds, borrowings, and amounts from the Fund’s affiliates that are subject to repayment by shareholders.

Investments in Longevity Assets are highly speculative and involves risks that the Fund may not be able to collect on the insurance policy. With respect to Mortality Contracts, the insured may live longer than anticipated. With respect to Annuity Contracts, the annuitant may not live as long as anticipated.

In recent years, many life insurance issuers have instituted premium increases for Mortality Contracts. In many instances, these increases were material. The Fund cannot predict with certainty when or if this might occur. There can be no assurance Mortality Contracts acquired by the Fund will not be subject to premium and other cost increases. If any such Mortality Contracts are affected by a cost increase, the value of such Mortality Contracts may be materially reduced and the Fund may decide or may be forced to sell or allow such Mortality Contracts to lapse, resulting in a loss to the Fund.

Distributions are not guaranteed. The Fund intends to qualify as a Regulated Investment Company under Subchapter M of the Internal Revenue Code. Distributions may be characterized as ordinary income, qualified dividends, capital gains, or return of capital. Diversification does not assure a profit or protect against loss.

This information is neither an offer to sell, nor a solicitation of an offer to buy, an interest in the Fund or any other investment fund managed by Abacus, which can only be made to investors pursuant to and as described in a fund’s prospectus (or similar offering documentation with respect to privately placed funds that are not registered under the 1940 Act). This information is qualified in its entirety by the offering materials for the Fund and is obtained from sources believed to be reliable for purposes herein. Abacus makes no representation or warranty, express or implied, as to the accuracy and completeness of the information contained herein. Certain economic and market conditions contained herein have been obtained from published sources and/or prepared by third parties and in certain cases have not been updated through the date hereof. All information contained herein is subject to revision, and the information set forth herein does not purport to be complete. In addition, certain statements herein reflect the subjective views and opinions of Abacus. Such statements cannot be independently verified and are subject to change.

The Fund’s offering materials contain important details concerning investment objectives, strategies, fees, expenses, conflicts of interest and risks and should be carefully reviewed in their entirety before investing. The prospectus should be read carefully before investing.

The prospectus, amended prospectus, and other information are available for free on the SEC’s website (www.sec.gov). This information is for informational purposes only and does not constitute an offer or solicitation by anyone in any jurisdiction in which such offer or solicitation is not authorized or to any person whom it is unlawful to make such offer or solicitation.

The service providers of the Fund are set forth in the Fund’s offering materials, and, in certain cases, are affiliates of Abacus. Under certain circumstances, the interests of AAM and its affiliates and their respective clients may conflict with the interests of the Fund or one or more other funds managed by AAM. By investing in the Fund, each investor will be deemed to have acknowledged the existence of such actual and potential conflicts and to have waived any claim with respect to any liability arising from the existence of such conflict.

In considering any prior, pro forma performance, portfolio composition or track record information contained herein, prospective investors should bear in mind that past performance is not indicative of future results. There can be no assurance that the Fund will achieve comparable results or that objectives will be achieved. Investments are speculative, involve a high degree of risk and performance can be volatile. Past performance does not guarantee future results; current performance may be lower or higher than performance quoted.

The opinions expressed are as of the date set forth herein, are subject to change at any time without notice and do not constitute investment, legal, tax, accounting or professional advice. This information cannot be relied upon for tax purposes and does not constitute investment advice or a recommendation to buy or sell any security and is subject to change without notice. Each investor should consult with their own legal, tax, and financial advisors regarding the suitability of the Fund described herein.

ABL Wealth Advisors LLC D/B/A Abacus Asset Management is an investment adviser registered as such with the U.S. Securities and Exchange Commission (“SEC”) pursuant to the Investment Advisers Act of 1940, as amended. Abacus Asset Management is a subsidiary of Abacus Global Management. Abacus Asset Management business is described in Form ADV, Part 1 and 2, which can be obtained from the SEC at https://adviserinfo.sec.gov/ or upon request.

The Fund is distributed by Distribution Services, LLC Member FINRA.

* Longevity assets returns are based on medical data, actuarial tables, demographics and mortality events.

* The Management Fee is calculated at the rate of 1.45% per annum (0.003972% per day for a 365-day year), based on the end-of-day value of the Fund’s AUM. For purposes of calculating the Management Fee, AUM is calculated as the sum of (a) the face value of any cash and cash equivalent assets and the fair value of any other assets other than Mortality Contracts and Annuity Contracts, plus (b) the market value of any securities for which there is a readily available market quotation, plus (c) in the case of each Mortality Contract, the lower of (x) the purchase price of a Mortality Contract plus any premiums paid therefor, or (y) the Manager’s current fair value of the Mortality Contract, plus (d) in the case of each annuity contract, the lower of (x) the purchase price of an Annuity Contract less any dividends received therefor, or (y) the Manager’s current fair value of the Annuity Contract, less (d) any debt incurred by the Fund and other Fund liabilities and expenses. The Manager expects that under normal market conditions, the majority of its fair-valued assets (i.e., Mortality Contracts), will increase in value over time while the fair value of its Annuity Contracts will be written down as they pay out dividends. As a result, the AUM used to calculate the Management Fee may be lower (but will never be higher) than the NAV amount shown above.

© 2026 ABL Wealth Advisors LLC D/B/A Abacus Asset Management Advisors, LLC, 333 S Garland Ave, Suite 1500, Orlando, FL 32801.